These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19845743)
1. Treatment practices in adults with chronic immune thrombocytopenia - a European perspective. Rodeghiero F; Besalduch J; Michel M; Provan D; Grotzinger K; Thompson G Eur J Haematol; 2010 Feb; 84(2):160-8. PubMed ID: 19845743 [TBL] [Abstract][Full Text] [Related]
2. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
3. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808 [TBL] [Abstract][Full Text] [Related]
5. [Introduction of laparoscopic splenectomy for the treatment of immune thrombocytopenic purpura]. Kiudelis M; Endzinas Z; Mickevicius A; Reckauskas M Zentralbl Chir; 2004 Apr; 129(2):108-13. PubMed ID: 15106041 [TBL] [Abstract][Full Text] [Related]
6. Current options for the treatment of idiopathic thrombocytopenic purpura. Arnold DM; Kelton JG Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the impact and burden of illness of adult chronic ITP in the US. Saleh MN; Fisher M; Grotzinger KM Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465 [TBL] [Abstract][Full Text] [Related]
8. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia]. Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038 [TBL] [Abstract][Full Text] [Related]
10. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases. Li HQ; Zhang L; Zhao H; Ji LX; Yang RC Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223 [TBL] [Abstract][Full Text] [Related]
11. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
13. Management of patients with refractory immune thrombocytopenic purpura. George JN J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M; Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672 [TBL] [Abstract][Full Text] [Related]